1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Predicting the rate of oxygen consumption during the 3-minute constant-rate stair stepping and shuttle tests in people with chronic obstructive pulmonary disease
(
- Contribution to journal › Article
- 2016
-
Mark
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
(
- Contribution to journal › Article
-
Mark
Author’s reply
(
- Contribution to journal › Letter
- 2015
-
Mark
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
(
- Contribution to journal › Article
-
Mark
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
(
- Contribution to journal › Article